Articles published by GlobeNewswire
Via GlobeNewswire
Tickers
KRG
Anapol Weiss Secures Key EFAA Rulings Keeping Child-Exploitation Claims in Open Court
February 24, 2026
From Anapol Weiss
Via GlobeNewswire
Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives
February 24, 2026
Via GlobeNewswire
Tickers
HOWL
Pomerantz Law Firm Announces the Filing of a Class Action Against Lakeland Industries, Inc.and Certain Officers – LAKE
February 24, 2026
From Pomerantz LLP
Via GlobeNewswire
Tickers
LAKE
Pomerantz Law Firm Announces the Filing of a Class Action Against Plug Power Inc. and Certain Officers – PLUG
February 24, 2026
From Pomerantz LLP
Via GlobeNewswire
Tickers
PLUG
Valley National Bancorp Announces Adoption of Share Repurchase Program
February 24, 2026
From Valley National Bank
Via GlobeNewswire
Tickers
VLY
Vaxcyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 24, 2026
From Vaxcyte, Inc.
Via GlobeNewswire
Tickers
PCVX
Datadog to Present at Upcoming Investor Conference
February 24, 2026
From Datadog, Inc.
Via GlobeNewswire
Tickers
DDOG
Appian Corporation to Present at the Morgan Stanley Technology, Media & Telecom Conference
February 24, 2026
From Appian Corporation
Via GlobeNewswire
Tickers
APPN
Spyre Therapeutics to Participate in Upcoming March Investor Conferences
February 24, 2026
Via GlobeNewswire
Tickers
SYRE
Rapport Therapeutics to Participate in Upcoming Investor Conferences
February 24, 2026
Via GlobeNewswire
Tickers
RAPP
Via GlobeNewswire
Tickers
SUPN
Valley National Bancorp Declares Its Regular Quarterly Preferred and Common Stock Dividends
February 24, 2026
From Valley National Bank
Via GlobeNewswire
Tickers
VLY
Navitas Semiconductor Announces Fourth Quarter and Full Year 2025 Financial Results
February 24, 2026
Via GlobeNewswire
Tickers
NVTS
ABM to Announce First Quarter 2026 Financial Results
February 24, 2026
Via GlobeNewswire
Tickers
ABM
From UroGen Pharma Ltd.
Via GlobeNewswire
Tickers
URGN
Palvella Therapeutics Announces Proposed Public Offering
February 24, 2026
Via GlobeNewswire
Tickers
PVLA
Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results
February 24, 2026
From Ceribell
Via GlobeNewswire
Tickers
CBLL
Aktis Oncology to Present at Upcoming March Investor Conferences
February 24, 2026
From Aktis Oncology Inc.
Via GlobeNewswire
Tickers
AKTS
From Rapid7
Via GlobeNewswire
Tickers
RPD
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INO
February 24, 2026
From Pomerantz LLP
Via GlobeNewswire
Tickers
INO
Flywire Reports Fourth Quarter and Fiscal-Year 2025 Financial Results
February 24, 2026
From Flywire Corporation
Via GlobeNewswire
Tickers
FLYW
Bicara Therapeutics Announces Proposed Public Offering of Common Stock
February 24, 2026
Via GlobeNewswire
Tickers
BCAX
From EXL
Via GlobeNewswire
Tickers
EXLS
Via GlobeNewswire
Tickers
MU
BridgeBio Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial Updates
February 24, 2026
Via GlobeNewswire
Tickers
BBIO
SLR Investment Corp. Announces Quarter and Year Ended December 31, 2025 Financial Results
February 24, 2026
From SLR Investment Corp.
Via GlobeNewswire
Tickers
SLRC
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.